The data demonstrate that the AD-associated CD33 rs3865444CC risk allele modulates the interaction between CD33 and SHP-1 in a phosphorylation-sensitive manner, potentially contributing to altered microglial function in AD. Here, CD33 is linked to Alzheimer disease.